PCBD1 and diabetes mellitus: Thus, in order to optimize the clinical management in this subset of patients, screening for biallelic mutations in PCBD1 has been suggested in the case of HNF1A-like diabetes occurrence with absent alterations in HNF1A and HNF1B.